| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Selenoproteins | 55 | 2022 | 159 | 8.780 |
Why?
|
| Selenium | 43 | 2024 | 148 | 8.040 |
Why?
|
| Selenocysteine | 37 | 2024 | 55 | 5.280 |
Why?
|
| Selenoprotein P | 20 | 2022 | 50 | 4.330 |
Why?
|
| Lyases | 10 | 2021 | 51 | 4.190 |
Why?
|
| Iodide Peroxidase | 28 | 2021 | 35 | 2.760 |
Why?
|
| Protein Biosynthesis | 23 | 2007 | 133 | 2.260 |
Why?
|
| Proteins | 18 | 2003 | 369 | 2.100 |
Why?
|
| RNA, Messenger | 27 | 2017 | 1207 | 1.980 |
Why?
|
| Schools, Medical | 5 | 2018 | 198 | 1.770 |
Why?
|
| Animals | 92 | 2024 | 15081 | 1.760 |
Why?
|
| Leptin | 5 | 2021 | 118 | 1.690 |
Why?
|
| RNA-Binding Proteins | 14 | 2009 | 146 | 1.640 |
Why?
|
| Energy Metabolism | 7 | 2021 | 168 | 1.640 |
Why?
|
| RNA, Transfer, Amino Acid-Specific | 6 | 2021 | 14 | 1.540 |
Why?
|
| Mercury | 3 | 2024 | 39 | 1.530 |
Why?
|
| Codon | 13 | 2006 | 42 | 1.380 |
Why?
|
| Hypothalamus | 4 | 2019 | 129 | 1.370 |
Why?
|
| Obesity | 8 | 2021 | 1067 | 1.360 |
Why?
|
| Molecular Biology | 3 | 2015 | 46 | 1.330 |
Why?
|
| Brain | 9 | 2017 | 1346 | 1.270 |
Why?
|
| Sex Characteristics | 3 | 2021 | 230 | 1.130 |
Why?
|
| Mice, Knockout | 15 | 2021 | 933 | 1.120 |
Why?
|
| Cell Line | 27 | 2014 | 1354 | 1.090 |
Why?
|
| Oxidative Stress | 16 | 2021 | 938 | 1.070 |
Why?
|
| Mice | 34 | 2021 | 5913 | 1.070 |
Why?
|
| Neurons | 5 | 2022 | 1175 | 1.010 |
Why?
|
| Glutathione Peroxidase | 13 | 2022 | 111 | 0.950 |
Why?
|
| Seafood | 4 | 2024 | 23 | 0.940 |
Why?
|
| Humans | 78 | 2024 | 37093 | 0.920 |
Why?
|
| Nerve Tissue Proteins | 3 | 2015 | 360 | 0.880 |
Why?
|
| Cell Biology | 2 | 2014 | 12 | 0.860 |
Why?
|
| Mice, Inbred C57BL | 13 | 2021 | 1609 | 0.830 |
Why?
|
| Eukaryotic Cells | 7 | 2008 | 36 | 0.820 |
Why?
|
| Body Weight | 4 | 2021 | 434 | 0.820 |
Why?
|
| Codon, Terminator | 8 | 2013 | 12 | 0.800 |
Why?
|
| Endocrinology | 1 | 2021 | 2 | 0.780 |
Why?
|
| Adipocytes, Brown | 1 | 2021 | 8 | 0.760 |
Why?
|
| Thermogenesis | 1 | 2021 | 20 | 0.760 |
Why?
|
| Cysteine | 9 | 2024 | 98 | 0.750 |
Why?
|
| RNA, Transfer, Amino Acyl | 9 | 2013 | 9 | 0.720 |
Why?
|
| Peptide Elongation Factors | 7 | 2008 | 11 | 0.700 |
Why?
|
| Agouti-Related Protein | 1 | 2019 | 12 | 0.690 |
Why?
|
| Gene Deletion | 4 | 2021 | 166 | 0.680 |
Why?
|
| Universities | 2 | 2015 | 442 | 0.680 |
Why?
|
| Glutathione | 5 | 2007 | 179 | 0.670 |
Why?
|
| 3' Untranslated Regions | 3 | 2008 | 74 | 0.670 |
Why?
|
| Fetal Blood | 2 | 2015 | 50 | 0.610 |
Why?
|
| Thyroid Hormones | 5 | 2005 | 27 | 0.610 |
Why?
|
| Molecular Sequence Data | 24 | 2014 | 1568 | 0.590 |
Why?
|
| Adipose Tissue, Brown | 4 | 2021 | 38 | 0.570 |
Why?
|
| Transfection | 18 | 2017 | 523 | 0.570 |
Why?
|
| Amino Acid Sequence | 21 | 2014 | 1180 | 0.560 |
Why?
|
| Male | 26 | 2023 | 20025 | 0.540 |
Why?
|
| Research | 2 | 2015 | 163 | 0.540 |
Why?
|
| Liver | 11 | 2021 | 479 | 0.540 |
Why?
|
| Female | 23 | 2024 | 20969 | 0.530 |
Why?
|
| Curriculum | 1 | 2018 | 265 | 0.530 |
Why?
|
| DNA-Binding Proteins | 3 | 2009 | 539 | 0.520 |
Why?
|
| Behavior, Animal | 2 | 2014 | 314 | 0.500 |
Why?
|
| Phosphotransferases | 7 | 2014 | 35 | 0.490 |
Why?
|
| Bambusa | 3 | 2010 | 10 | 0.490 |
Why?
|
| Gene Expression Regulation | 8 | 2017 | 1015 | 0.490 |
Why?
|
| Education, Graduate | 2 | 2014 | 27 | 0.490 |
Why?
|
| Neurodegenerative Diseases | 2 | 2014 | 131 | 0.490 |
Why?
|
| Nucleic Acid Conformation | 7 | 2006 | 146 | 0.480 |
Why?
|
| Up-Regulation | 4 | 2015 | 513 | 0.480 |
Why?
|
| Biomedical Research | 4 | 2023 | 400 | 0.460 |
Why?
|
| Seizures | 1 | 2014 | 68 | 0.460 |
Why?
|
| Blotting, Western | 9 | 2015 | 859 | 0.450 |
Why?
|
| Hawaii | 8 | 2023 | 1929 | 0.450 |
Why?
|
| Palmitic Acid | 2 | 2015 | 24 | 0.440 |
Why?
|
| Mammals | 4 | 2009 | 105 | 0.410 |
Why?
|
| Base Sequence | 16 | 2007 | 997 | 0.410 |
Why?
|
| Putamen | 1 | 2012 | 15 | 0.410 |
Why?
|
| Genome, Human | 1 | 2013 | 135 | 0.410 |
Why?
|
| Substantia Nigra | 1 | 2012 | 44 | 0.400 |
Why?
|
| Transcription, Genetic | 5 | 2009 | 578 | 0.400 |
Why?
|
| Plant Extracts | 3 | 2011 | 286 | 0.390 |
Why?
|
| Antioxidants | 5 | 2013 | 416 | 0.390 |
Why?
|
| DNA Transposable Elements | 2 | 2002 | 48 | 0.370 |
Why?
|
| Cloning, Molecular | 6 | 2021 | 325 | 0.370 |
Why?
|
| Superoxides | 2 | 2007 | 53 | 0.370 |
Why?
|
| Placenta | 3 | 2024 | 97 | 0.370 |
Why?
|
| Glutathione Transferase | 3 | 2010 | 88 | 0.370 |
Why?
|
| Cytosol | 1 | 2010 | 93 | 0.360 |
Why?
|
| Parkinson Disease | 1 | 2012 | 178 | 0.360 |
Why?
|
| Fishes | 2 | 2024 | 53 | 0.350 |
Why?
|
| Dietary Supplements | 4 | 2016 | 208 | 0.350 |
Why?
|
| Cognition | 1 | 2013 | 398 | 0.350 |
Why?
|
| Disease | 1 | 2009 | 18 | 0.350 |
Why?
|
| Flow Cytometry | 2 | 2008 | 399 | 0.340 |
Why?
|
| Ribosomes | 2 | 2006 | 32 | 0.340 |
Why?
|
| Transcription Factors | 2 | 2015 | 681 | 0.340 |
Why?
|
| Methylmercury Compounds | 1 | 2009 | 4 | 0.340 |
Why?
|
| Mercury Poisoning | 1 | 2009 | 5 | 0.340 |
Why?
|
| Ribosomal Proteins | 2 | 2008 | 21 | 0.340 |
Why?
|
| Gene Expression | 11 | 2012 | 674 | 0.330 |
Why?
|
| Alzheimer Disease | 3 | 2015 | 905 | 0.320 |
Why?
|
| Immunity | 1 | 2008 | 53 | 0.320 |
Why?
|
| Drosophila Proteins | 2 | 2003 | 171 | 0.320 |
Why?
|
| Pregnancy | 5 | 2024 | 1549 | 0.320 |
Why?
|
| Zebrafish Proteins | 2 | 2006 | 47 | 0.320 |
Why?
|
| Methamphetamine | 3 | 2015 | 159 | 0.310 |
Why?
|
| Membrane Proteins | 3 | 2017 | 517 | 0.310 |
Why?
|
| Cell Nucleus | 3 | 2006 | 366 | 0.310 |
Why?
|
| Databases, Protein | 1 | 2008 | 48 | 0.310 |
Why?
|
| Proteome | 2 | 2007 | 144 | 0.310 |
Why?
|
| Mutagenesis, Site-Directed | 7 | 2003 | 188 | 0.300 |
Why?
|
| RNA Stability | 1 | 2007 | 26 | 0.300 |
Why?
|
| Lymphocyte Subsets | 1 | 2007 | 21 | 0.300 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2007 | 16 | 0.300 |
Why?
|
| Weight Gain | 2 | 2019 | 136 | 0.300 |
Why?
|
| Lung | 2 | 2007 | 446 | 0.300 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2007 | 4 | 0.300 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2007 | 12 | 0.300 |
Why?
|
| Hippocampus | 3 | 2007 | 561 | 0.300 |
Why?
|
| Apoferritins | 1 | 2007 | 5 | 0.300 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 245 | 0.300 |
Why?
|
| Adiposity | 2 | 2019 | 154 | 0.290 |
Why?
|
| Calcium | 1 | 2010 | 480 | 0.290 |
Why?
|
| Minority Groups | 3 | 2023 | 596 | 0.290 |
Why?
|
| RNA, Transfer | 7 | 2008 | 28 | 0.290 |
Why?
|
| Rats | 20 | 2013 | 3483 | 0.280 |
Why?
|
| Asthma | 2 | 2008 | 380 | 0.280 |
Why?
|
| Cerebral Cortex | 1 | 2008 | 290 | 0.280 |
Why?
|
| Signal Transduction | 3 | 2021 | 1908 | 0.280 |
Why?
|
| Chemoprevention | 1 | 2006 | 35 | 0.280 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 168 | 0.280 |
Why?
|
| Pre-Eclampsia | 2 | 2019 | 61 | 0.280 |
Why?
|
| Diet | 5 | 2016 | 801 | 0.280 |
Why?
|
| Tetraodontiformes | 1 | 2005 | 3 | 0.270 |
Why?
|
| Fish Proteins | 1 | 2005 | 11 | 0.270 |
Why?
|
| Cells, Cultured | 4 | 2021 | 1518 | 0.270 |
Why?
|
| Multiprotein Complexes | 1 | 2006 | 54 | 0.260 |
Why?
|
| Thioredoxin-Disulfide Reductase | 2 | 2009 | 5 | 0.260 |
Why?
|
| Glucose Intolerance | 2 | 2018 | 42 | 0.260 |
Why?
|
| Buthionine Sulfoximine | 1 | 2005 | 12 | 0.260 |
Why?
|
| Mutation, Missense | 1 | 2005 | 83 | 0.260 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2009 | 623 | 0.250 |
Why?
|
| Blood Glucose | 2 | 2018 | 353 | 0.250 |
Why?
|
| Protein Structure, Tertiary | 4 | 2014 | 408 | 0.240 |
Why?
|
| Age Factors | 2 | 2018 | 1033 | 0.230 |
Why?
|
| Mutation | 7 | 2017 | 1095 | 0.230 |
Why?
|
| Mitochondria | 1 | 2007 | 487 | 0.230 |
Why?
|
| Brain Diseases | 1 | 2003 | 32 | 0.230 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2000 | 49 | 0.220 |
Why?
|
| Sequence Homology, Amino Acid | 9 | 2006 | 269 | 0.220 |
Why?
|
| Gene Knockdown Techniques | 3 | 2014 | 173 | 0.220 |
Why?
|
| Recombinant Proteins | 6 | 2008 | 515 | 0.210 |
Why?
|
| Sequence Alignment | 5 | 2014 | 265 | 0.210 |
Why?
|
| Genes | 3 | 2019 | 60 | 0.210 |
Why?
|
| Organoselenium Compounds | 2 | 2020 | 10 | 0.210 |
Why?
|
| Amnion | 2 | 2014 | 16 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 2 | 2021 | 474 | 0.210 |
Why?
|
| History, 21st Century | 2 | 2021 | 81 | 0.210 |
Why?
|
| Drosophila melanogaster | 1 | 2003 | 180 | 0.210 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 1371 | 0.200 |
Why?
|
| History, 20th Century | 2 | 2021 | 117 | 0.200 |
Why?
|
| Peptide Chain Termination, Translational | 1 | 2001 | 1 | 0.200 |
Why?
|
| Peptide Termination Factors | 1 | 2001 | 3 | 0.200 |
Why?
|
| Education, Medical | 2 | 2018 | 104 | 0.200 |
Why?
|
| Glucose Tolerance Test | 1 | 2021 | 68 | 0.200 |
Why?
|
| Cell Line, Tumor | 5 | 2017 | 2231 | 0.200 |
Why?
|
| Carbon Dioxide | 1 | 2021 | 77 | 0.190 |
Why?
|
| Polyribosomes | 1 | 2001 | 3 | 0.190 |
Why?
|
| Simvastatin | 1 | 2021 | 29 | 0.190 |
Why?
|
| Amino Acids | 2 | 2019 | 145 | 0.190 |
Why?
|
| Protein Binding | 6 | 2007 | 972 | 0.190 |
Why?
|
| Biosynthetic Pathways | 1 | 2021 | 13 | 0.190 |
Why?
|
| RNA Precursors | 2 | 2014 | 27 | 0.190 |
Why?
|
| Binding Sites | 5 | 2007 | 651 | 0.190 |
Why?
|
| RNA | 2 | 2005 | 241 | 0.190 |
Why?
|
| Azoles | 1 | 2020 | 14 | 0.180 |
Why?
|
| Oxidation-Reduction | 3 | 2018 | 431 | 0.180 |
Why?
|
| Genes, Reporter | 3 | 2009 | 136 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 3 | 2014 | 515 | 0.180 |
Why?
|
| Genes, Helminth | 1 | 1999 | 7 | 0.180 |
Why?
|
| Metabolome | 1 | 2019 | 53 | 0.170 |
Why?
|
| Gene Knockout Techniques | 1 | 2019 | 51 | 0.170 |
Why?
|
| Nutritional Status | 2 | 2020 | 116 | 0.170 |
Why?
|
| Kidney | 6 | 2009 | 337 | 0.170 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 282 | 0.170 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 68 | 0.160 |
Why?
|
| Behavioral Research | 1 | 2019 | 39 | 0.160 |
Why?
|
| Caenorhabditis elegans | 1 | 1999 | 78 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 76 | 0.160 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 2379 | 0.160 |
Why?
|
| DNA Primers | 3 | 2009 | 286 | 0.160 |
Why?
|
| Selenium Radioisotopes | 4 | 2002 | 4 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2012 | 269 | 0.160 |
Why?
|
| Minority Health | 1 | 2019 | 88 | 0.160 |
Why?
|
| Cell Survival | 3 | 2008 | 864 | 0.160 |
Why?
|
| Orchiectomy | 1 | 2018 | 35 | 0.160 |
Why?
|
| Histidine | 2 | 2000 | 42 | 0.150 |
Why?
|
| Ovalbumin | 2 | 2007 | 47 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2019 | 628 | 0.150 |
Why?
|
| Time Factors | 3 | 2018 | 1742 | 0.150 |
Why?
|
| Cytoplasm | 3 | 2006 | 143 | 0.150 |
Why?
|
| Models, Biological | 5 | 2007 | 677 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2010 | 259 | 0.140 |
Why?
|
| Phosphoproteins | 2 | 2008 | 163 | 0.140 |
Why?
|
| Protein Isoforms | 2 | 2014 | 130 | 0.140 |
Why?
|
| Aging | 3 | 2015 | 664 | 0.140 |
Why?
|
| Isoenzymes | 2 | 1997 | 161 | 0.140 |
Why?
|
| Neoplasms | 1 | 2006 | 1103 | 0.140 |
Why?
|
| Faculty, Medical | 2 | 2014 | 66 | 0.140 |
Why?
|
| Epilepsy, Reflex | 1 | 2015 | 5 | 0.140 |
Why?
|
| Castration | 1 | 2015 | 34 | 0.130 |
Why?
|
| Glutamate Decarboxylase | 1 | 2015 | 19 | 0.130 |
Why?
|
| Food, Fortified | 1 | 2016 | 17 | 0.130 |
Why?
|
| Insulin | 1 | 2018 | 236 | 0.130 |
Why?
|
| Dizocilpine Maleate | 1 | 2015 | 48 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2016 | 643 | 0.130 |
Why?
|
| Thyroid Gland | 2 | 1995 | 19 | 0.130 |
Why?
|
| Child | 1 | 2024 | 3131 | 0.130 |
Why?
|
| RNA, Transfer, Ser | 2 | 2006 | 3 | 0.130 |
Why?
|
| tau Proteins | 1 | 2017 | 167 | 0.130 |
Why?
|
| Exploratory Behavior | 1 | 2015 | 75 | 0.130 |
Why?
|
| Maze Learning | 1 | 2015 | 105 | 0.130 |
Why?
|
| Autoantigens | 2 | 2006 | 81 | 0.130 |
Why?
|
| Genotype | 1 | 2018 | 730 | 0.130 |
Why?
|
| Calcium Channels, L-Type | 1 | 2015 | 20 | 0.130 |
Why?
|
| Heat-Shock Proteins | 1 | 2015 | 55 | 0.130 |
Why?
|
| Iodine | 2 | 1997 | 6 | 0.130 |
Why?
|
| Phenotype | 1 | 2018 | 689 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 767 | 0.130 |
Why?
|
| Choroid Plexus | 1 | 2015 | 6 | 0.130 |
Why?
|
| Calcium Channel Blockers | 1 | 2015 | 56 | 0.130 |
Why?
|
| Animal Nutritional Physiological Phenomena | 1 | 1995 | 13 | 0.130 |
Why?
|
| Anticodon | 1 | 1994 | 1 | 0.130 |
Why?
|
| DNA | 6 | 2014 | 574 | 0.120 |
Why?
|
| Chorion | 1 | 2014 | 8 | 0.120 |
Why?
|
| Analysis of Variance | 2 | 2017 | 550 | 0.120 |
Why?
|
| Substrate Specificity | 2 | 2014 | 212 | 0.120 |
Why?
|
| Organogenesis | 1 | 2014 | 16 | 0.120 |
Why?
|
| RNA Helicases | 1 | 2014 | 16 | 0.120 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2014 | 29 | 0.120 |
Why?
|
| Archaea | 2 | 2007 | 18 | 0.120 |
Why?
|
| HIV Infections | 3 | 2015 | 2303 | 0.120 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2015 | 65 | 0.120 |
Why?
|
| Acquired Immunodeficiency Syndrome | 2 | 2008 | 215 | 0.120 |
Why?
|
| Point Mutation | 3 | 2003 | 93 | 0.120 |
Why?
|
| Phosphorylation | 4 | 2017 | 928 | 0.120 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2014 | 80 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2014 | 71 | 0.120 |
Why?
|
| DNA Mutational Analysis | 4 | 2003 | 93 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 617 | 0.110 |
Why?
|
| Mice, Inbred Strains | 1 | 1993 | 116 | 0.110 |
Why?
|
| Adult | 4 | 2024 | 11712 | 0.110 |
Why?
|
| Income | 1 | 2014 | 140 | 0.110 |
Why?
|
| Trans-Activators | 1 | 2014 | 174 | 0.110 |
Why?
|
| Inflammation | 2 | 2008 | 618 | 0.110 |
Why?
|
| Endocytosis | 1 | 2014 | 113 | 0.110 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 664 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2012 | 7 | 0.110 |
Why?
|
| Motor Activity | 1 | 2015 | 418 | 0.110 |
Why?
|
| Hyperinsulinism | 1 | 2012 | 17 | 0.110 |
Why?
|
| Locomotion | 1 | 2013 | 97 | 0.110 |
Why?
|
| Ligands | 1 | 2014 | 349 | 0.110 |
Why?
|
| Bacterial Proteins | 2 | 2007 | 540 | 0.110 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 42 | 0.110 |
Why?
|
| Zebrafish | 2 | 2006 | 128 | 0.110 |
Why?
|
| Alternative Splicing | 1 | 2012 | 85 | 0.110 |
Why?
|
| Hypercholesterolemia | 1 | 2012 | 38 | 0.110 |
Why?
|
| Sex Factors | 1 | 2015 | 898 | 0.100 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 58 | 0.100 |
Why?
|
| Stereotaxic Techniques | 1 | 2012 | 20 | 0.100 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 219 | 0.100 |
Why?
|
| Precipitin Tests | 2 | 2003 | 52 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2012 | 64 | 0.100 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2012 | 78 | 0.100 |
Why?
|
| alpha-Synuclein | 1 | 2012 | 52 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 2 | 2012 | 106 | 0.100 |
Why?
|
| Poaceae | 1 | 2011 | 11 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 306 | 0.100 |
Why?
|
| Dogs | 5 | 1999 | 149 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2014 | 325 | 0.090 |
Why?
|
| Open Reading Frames | 2 | 2001 | 77 | 0.090 |
Why?
|
| Microscopy, Confocal | 2 | 2008 | 218 | 0.090 |
Why?
|
| RNA Interference | 3 | 2012 | 243 | 0.090 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2010 | 19 | 0.090 |
Why?
|
| Chemokine CCL2 | 1 | 2011 | 85 | 0.090 |
Why?
|
| Glycosylation | 2 | 2000 | 100 | 0.090 |
Why?
|
| Oxidants | 1 | 2010 | 45 | 0.090 |
Why?
|
| Gene Silencing | 2 | 2008 | 151 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2014 | 454 | 0.090 |
Why?
|
| Kinetics | 5 | 1997 | 708 | 0.090 |
Why?
|
| Sulfhydryl Compounds | 1 | 2010 | 47 | 0.090 |
Why?
|
| Reactive Oxygen Species | 2 | 2010 | 461 | 0.090 |
Why?
|
| Macaca | 1 | 2009 | 38 | 0.090 |
Why?
|
| Luminescent Proteins | 1 | 2010 | 77 | 0.090 |
Why?
|
| Luciferases | 1 | 2009 | 63 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 1 | 2010 | 76 | 0.090 |
Why?
|
| Aged | 3 | 2017 | 6741 | 0.090 |
Why?
|
| Triiodothyronine | 3 | 1995 | 32 | 0.090 |
Why?
|
| RNA, Small Interfering | 4 | 2017 | 409 | 0.090 |
Why?
|
| Hydrogen Peroxide | 1 | 2010 | 190 | 0.080 |
Why?
|
| Genomics | 2 | 2008 | 223 | 0.080 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 236 | 0.080 |
Why?
|
| Homeostasis | 2 | 2022 | 188 | 0.080 |
Why?
|
| Telomerase | 1 | 2009 | 44 | 0.080 |
Why?
|
| Metals, Heavy | 1 | 2009 | 60 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2007 | 295 | 0.080 |
Why?
|
| Neocortex | 1 | 2008 | 27 | 0.080 |
Why?
|
| Telomere | 1 | 2009 | 56 | 0.080 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2008 | 29 | 0.080 |
Why?
|
| Cross-Linking Reagents | 1 | 2008 | 51 | 0.080 |
Why?
|
| Research Personnel | 2 | 2021 | 155 | 0.080 |
Why?
|
| Cell Count | 1 | 2008 | 135 | 0.080 |
Why?
|
| Protein Conformation | 2 | 2003 | 389 | 0.080 |
Why?
|
| Neurofibrillary Tangles | 1 | 2008 | 113 | 0.080 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2008 | 42 | 0.080 |
Why?
|
| Depression | 1 | 2015 | 712 | 0.080 |
Why?
|
| Tissue Distribution | 2 | 2007 | 207 | 0.080 |
Why?
|
| Vero Cells | 1 | 2008 | 93 | 0.080 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2008 | 70 | 0.080 |
Why?
|
| Phytotherapy | 1 | 2008 | 81 | 0.080 |
Why?
|
| Prokaryotic Cells | 2 | 1999 | 9 | 0.080 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2007 | 18 | 0.080 |
Why?
|
| Diabetic Nephropathies | 1 | 2008 | 61 | 0.080 |
Why?
|
| Sequence Analysis, Protein | 1 | 2008 | 50 | 0.080 |
Why?
|
| STAT6 Transcription Factor | 1 | 2007 | 16 | 0.080 |
Why?
|
| User-Computer Interface | 1 | 2008 | 62 | 0.080 |
Why?
|
| Malonates | 1 | 2007 | 2 | 0.080 |
Why?
|
| Polyenes | 1 | 2007 | 4 | 0.080 |
Why?
|
| Antimycin A | 1 | 2007 | 5 | 0.080 |
Why?
|
| Electron Transport Complex II | 1 | 2007 | 7 | 0.080 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2007 | 56 | 0.080 |
Why?
|
| Electron Transport Complex III | 1 | 2007 | 13 | 0.080 |
Why?
|
| High Mobility Group Proteins | 1 | 2007 | 4 | 0.080 |
Why?
|
| Rotenone | 1 | 2007 | 19 | 0.080 |
Why?
|
| Th2 Cells | 1 | 2007 | 58 | 0.080 |
Why?
|
| Electron Transport Complex I | 1 | 2007 | 21 | 0.070 |
Why?
|
| Immunoglobulin E | 1 | 2007 | 55 | 0.070 |
Why?
|
| Plasmids | 2 | 2003 | 246 | 0.070 |
Why?
|
| Astrocytes | 1 | 2010 | 255 | 0.070 |
Why?
|
| Homocysteine | 1 | 2007 | 19 | 0.070 |
Why?
|
| HIV-1 | 1 | 2013 | 706 | 0.070 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2008 | 94 | 0.070 |
Why?
|
| Allergens | 1 | 2007 | 63 | 0.070 |
Why?
|
| Rats, Inbred Strains | 3 | 1991 | 133 | 0.070 |
Why?
|
| Mice, Obese | 2 | 2021 | 40 | 0.070 |
Why?
|
| Leishmania | 1 | 2006 | 17 | 0.070 |
Why?
|
| Conserved Sequence | 3 | 1997 | 119 | 0.070 |
Why?
|
| DNA Damage | 1 | 2009 | 352 | 0.070 |
Why?
|
| Environmental Pollutants | 1 | 2009 | 179 | 0.070 |
Why?
|
| Ultraviolet Rays | 1 | 2007 | 117 | 0.070 |
Why?
|
| Sequence Deletion | 1 | 2006 | 87 | 0.070 |
Why?
|
| Nuclear Export Signals | 1 | 2006 | 2 | 0.070 |
Why?
|
| Genetic Code | 1 | 2006 | 7 | 0.070 |
Why?
|
| Nuclear Localization Signals | 1 | 2006 | 17 | 0.070 |
Why?
|
| Internet | 1 | 2008 | 211 | 0.070 |
Why?
|
| Trace Elements | 2 | 2016 | 30 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2006 | 59 | 0.070 |
Why?
|
| Testis | 1 | 2007 | 187 | 0.070 |
Why?
|
| Protein Sorting Signals | 1 | 2005 | 26 | 0.070 |
Why?
|
| Homozygote | 1 | 2005 | 77 | 0.070 |
Why?
|
| Macromolecular Substances | 1 | 2005 | 96 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 1 | 2007 | 661 | 0.070 |
Why?
|
| Antigens | 1 | 2005 | 56 | 0.070 |
Why?
|
| Heterozygote | 1 | 2005 | 93 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2005 | 172 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2005 | 60 | 0.060 |
Why?
|
| Multigene Family | 1 | 2005 | 106 | 0.060 |
Why?
|
| Myocardium | 1 | 2007 | 235 | 0.060 |
Why?
|
| Protozoan Proteins | 1 | 2006 | 182 | 0.060 |
Why?
|
| Evolution, Molecular | 1 | 2006 | 268 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 77 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2005 | 140 | 0.060 |
Why?
|
| Skin | 1 | 2005 | 174 | 0.060 |
Why?
|
| Neuroblastoma | 2 | 2017 | 129 | 0.060 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 37 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2019 | 1130 | 0.060 |
Why?
|
| Cytoprotection | 1 | 2003 | 36 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2005 | 272 | 0.060 |
Why?
|
| Selenoprotein W | 1 | 2003 | 1 | 0.060 |
Why?
|
| Cytokines | 1 | 2007 | 602 | 0.060 |
Why?
|
| Research Support as Topic | 2 | 2019 | 80 | 0.060 |
Why?
|
| Embryo, Nonmammalian | 1 | 2003 | 59 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 626 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2006 | 753 | 0.060 |
Why?
|
| Methionine | 1 | 2003 | 30 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2000 | 129 | 0.050 |
Why?
|
| In Situ Hybridization | 2 | 2000 | 129 | 0.050 |
Why?
|
| Hormones | 1 | 2022 | 55 | 0.050 |
Why?
|
| Computational Biology | 3 | 2014 | 293 | 0.050 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2002 | 57 | 0.050 |
Why?
|
| Macaca mulatta | 1 | 2002 | 128 | 0.050 |
Why?
|
| DNA, Complementary | 4 | 1995 | 191 | 0.050 |
Why?
|
| Phylogeny | 1 | 2005 | 644 | 0.050 |
Why?
|
| Consensus Sequence | 2 | 1999 | 24 | 0.050 |
Why?
|
| Databases, Nucleic Acid | 1 | 2002 | 27 | 0.050 |
Why?
|
| Mentors | 1 | 2023 | 127 | 0.050 |
Why?
|
| Program Development | 1 | 2023 | 233 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1039 | 0.050 |
Why?
|
| Blood-Brain Barrier | 1 | 2003 | 162 | 0.050 |
Why?
|
| Methanococcus | 1 | 2001 | 1 | 0.050 |
Why?
|
| Maryland | 1 | 2021 | 53 | 0.050 |
Why?
|
| Physical Chromosome Mapping | 1 | 2000 | 12 | 0.050 |
Why?
|
| Creatinine | 1 | 2021 | 103 | 0.050 |
Why?
|
| beta-Galactosidase | 1 | 2000 | 35 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2007 | 196 | 0.050 |
Why?
|
| Selenious Acid | 1 | 2020 | 3 | 0.050 |
Why?
|
| Isoindoles | 1 | 2020 | 18 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2023 | 661 | 0.050 |
Why?
|
| Apoptosis | 1 | 2008 | 1398 | 0.050 |
Why?
|
| Sulfotransferases | 2 | 2010 | 7 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 2000 | 67 | 0.040 |
Why?
|
| Virulence | 1 | 2020 | 223 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 502 | 0.040 |
Why?
|
| Antibodies | 1 | 2000 | 141 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2006 | 90 | 0.040 |
Why?
|
| Oligonucleotides | 1 | 1999 | 49 | 0.040 |
Why?
|
| Metabolomics | 1 | 2019 | 81 | 0.040 |
Why?
|
| Rabbits | 1 | 1999 | 283 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2019 | 114 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2019 | 122 | 0.040 |
Why?
|
| Virus Replication | 1 | 2020 | 278 | 0.040 |
Why?
|
| Risk Factors | 1 | 2006 | 3562 | 0.040 |
Why?
|
| MicroRNAs | 2 | 2014 | 426 | 0.040 |
Why?
|
| Cattle | 1 | 1999 | 477 | 0.040 |
Why?
|
| Cultural Diversity | 1 | 2019 | 169 | 0.040 |
Why?
|
| Cell Death | 2 | 2010 | 267 | 0.040 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1995 | 28 | 0.040 |
Why?
|
| Structure-Activity Relationship | 3 | 1997 | 409 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 935 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 1997 | 183 | 0.040 |
Why?
|
| Leucine | 1 | 2017 | 29 | 0.040 |
Why?
|
| Chromosome Mapping | 2 | 1995 | 188 | 0.040 |
Why?
|
| Proline | 1 | 2017 | 43 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2016 | 34 | 0.040 |
Why?
|
| Catalysis | 2 | 1997 | 179 | 0.040 |
Why?
|
| Guanosine Triphosphate | 1 | 1995 | 18 | 0.030 |
Why?
|
| Metabolic Diseases | 1 | 2016 | 33 | 0.030 |
Why?
|
| Models, Molecular | 1 | 1999 | 808 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 893 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2006 | 1502 | 0.030 |
Why?
|
| Glucose | 1 | 2017 | 230 | 0.030 |
Why?
|
| Thyroxine | 1 | 1995 | 19 | 0.030 |
Why?
|
| Tilapia | 1 | 2014 | 7 | 0.030 |
Why?
|
| Philippines | 1 | 2014 | 73 | 0.030 |
Why?
|
| Blotting, Northern | 3 | 2005 | 150 | 0.030 |
Why?
|
| Pacific Islands | 1 | 2014 | 119 | 0.030 |
Why?
|
| Young Adult | 2 | 2014 | 4268 | 0.030 |
Why?
|
| Dementia | 1 | 2015 | 131 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2015 | 253 | 0.030 |
Why?
|
| Japan | 1 | 2014 | 305 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1993 | 89 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 33 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 1993 | 70 | 0.030 |
Why?
|
| Rats, Transgenic | 1 | 2013 | 27 | 0.030 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1993 | 28 | 0.030 |
Why?
|
| Untranslated Regions | 1 | 2012 | 6 | 0.030 |
Why?
|
| Ion Transport | 1 | 2012 | 17 | 0.030 |
Why?
|
| Diethyl Pyrocarbonate | 1 | 1992 | 1 | 0.030 |
Why?
|
| Rose Bengal | 1 | 1992 | 3 | 0.030 |
Why?
|
| RNA Splice Sites | 1 | 2012 | 10 | 0.030 |
Why?
|
| Half-Life | 1 | 1992 | 54 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1992 | 91 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2013 | 245 | 0.030 |
Why?
|
| Health Status Disparities | 1 | 2019 | 642 | 0.030 |
Why?
|
| Escherichia coli | 1 | 1995 | 453 | 0.030 |
Why?
|
| Congenital Hypothyroidism | 1 | 1992 | 4 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 333 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2014 | 435 | 0.030 |
Why?
|
| Chromosome Inversion | 1 | 1991 | 8 | 0.030 |
Why?
|
| Reticulocytes | 1 | 1991 | 9 | 0.030 |
Why?
|
| Aurothioglucose | 1 | 1991 | 1 | 0.030 |
Why?
|
| Peptides | 1 | 1994 | 320 | 0.020 |
Why?
|
| Xenopus | 1 | 1991 | 48 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 1991 | 111 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 1991 | 63 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1991 | 56 | 0.020 |
Why?
|
| Intra-Abdominal Fat | 1 | 2011 | 45 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 157 | 0.020 |
Why?
|
| Biotransformation | 1 | 2010 | 67 | 0.020 |
Why?
|
| Glucuronosyltransferase | 1 | 2010 | 25 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2010 | 32 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 1990 | 73 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 139 | 0.020 |
Why?
|
| Plant Leaves | 1 | 2010 | 124 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2010 | 92 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 133 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2010 | 89 | 0.020 |
Why?
|
| Energy Intake | 1 | 2010 | 170 | 0.020 |
Why?
|
| Oocytes | 1 | 1990 | 146 | 0.020 |
Why?
|
| United States | 1 | 2019 | 4223 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2014 | 2026 | 0.020 |
Why?
|
| Podocytes | 1 | 2008 | 35 | 0.020 |
Why?
|
| Flavonoids | 1 | 2008 | 87 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2009 | 326 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2008 | 55 | 0.020 |
Why?
|
| Kidney Glomerulus | 1 | 2008 | 84 | 0.020 |
Why?
|
| Radiation Tolerance | 1 | 2007 | 12 | 0.020 |
Why?
|
| Archaeal Proteins | 1 | 2007 | 9 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2009 | 305 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2007 | 45 | 0.020 |
Why?
|
| Transferases | 1 | 2007 | 12 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2007 | 19 | 0.020 |
Why?
|
| Dipeptides | 1 | 2007 | 32 | 0.020 |
Why?
|
| RNA, Protozoan | 1 | 2006 | 13 | 0.020 |
Why?
|
| DNA, Protozoan | 1 | 2006 | 24 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2007 | 99 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2010 | 587 | 0.020 |
Why?
|
| Chromatography | 1 | 2005 | 16 | 0.020 |
Why?
|
| Total Quality Management | 1 | 2005 | 9 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2005 | 61 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2007 | 289 | 0.020 |
Why?
|
| CHO Cells | 1 | 2005 | 124 | 0.020 |
Why?
|
| Serine | 1 | 2005 | 75 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 131 | 0.020 |
Why?
|
| Cricetinae | 1 | 2005 | 238 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2005 | 172 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 208 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2005 | 252 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2010 | 1198 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2008 | 1618 | 0.010 |
Why?
|
| Adolescent | 1 | 2014 | 5363 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2002 | 79 | 0.010 |
Why?
|
| Gene Products, tat | 1 | 2002 | 35 | 0.010 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2002 | 53 | 0.010 |
Why?
|
| Simian immunodeficiency virus | 1 | 2002 | 59 | 0.010 |
Why?
|
| HIV | 1 | 2002 | 98 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2005 | 1067 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 803 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 191 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 10129 | 0.010 |
Why?
|
| Disease Progression | 1 | 2002 | 601 | 0.010 |
Why?
|
| Propylthiouracil | 1 | 1997 | 3 | 0.010 |
Why?
|
| Dithiothreitol | 1 | 1997 | 18 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1997 | 58 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1995 | 45 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1995 | 31 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 1995 | 84 | 0.010 |
Why?
|
| Cell-Free System | 1 | 1995 | 15 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1995 | 80 | 0.010 |
Why?
|
| Microsomes | 1 | 1995 | 52 | 0.010 |
Why?
|
| Introns | 1 | 1995 | 75 | 0.010 |
Why?
|
| Pancreas | 1 | 1995 | 35 | 0.010 |
Why?
|
| Exons | 1 | 1995 | 88 | 0.010 |
Why?
|
| Kidney Cortex | 1 | 1993 | 8 | 0.010 |
Why?
|
| Kidney Medulla | 1 | 1993 | 6 | 0.010 |
Why?
|
| RNA Probes | 1 | 1993 | 10 | 0.010 |
Why?
|
| Genomic Library | 1 | 1992 | 7 | 0.010 |
Why?
|
| Affinity Labels | 1 | 1992 | 7 | 0.010 |
Why?
|